Japan Tobacco Inc. announced resolutions from the Board of Directors concerning the Company's new executive appointment. Newly appointed Executive Officer (Effective from July 1, 2024): Takayuki Yamaguchi as Senior Vice President, President, Pharmaceutical Business. Resigning Executive Officer (As of June 30, 2024): Muneaki Fujimoto as Senior Vice President, President, Pharmaceutical Business.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,452 JPY | +0.88% | -0.09% | +22.14% |
May. 14 | Jefferies Adjusts Japan Tobacco’s Price Target to 3,741 Yen From 3,353 Yen, Keeps at Hold | MT |
May. 10 | Japan Tobacco's Attributable Profit Up 9% in Q1 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.14% | 50.27B | |
+14.65% | 79.44B | |
-7.71% | 63.79B | |
-3.91% | 6.81B | |
-17.88% | 5.26B | |
-5.50% | 2.4B | |
-8.00% | 2.21B | |
-36.61% | 1.51B | |
-2.82% | 1.3B | |
-17.22% | 1.17B |
- Stock Market
- Equities
- 2914 Stock
- News Japan Tobacco, Inc.
- Japan Tobacco Inc. Announces Executive Changes